Nuveen Asset Management’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.92M | Buy |
269,115
+2,779
| +1% | +$71.4K | ﹤0.01% | 1811 |
|
|
2024
Q3 | $8.44M | Buy |
266,336
+11,043
| +4% | +$350K | ﹤0.01% | 1721 |
|
|
2024
Q2 | $8.96M | Sell |
255,293
-105,789
| -29% | -$3.71M | ﹤0.01% | 1640 |
|
|
2024
Q1 | $15.8M | Sell |
361,082
-17,831
| -5% | -$782K | ﹤0.01% | 1315 |
|
|
2023
Q4 | $13.5M | Sell |
378,913
-167,347
| -31% | -$5.95M | ﹤0.01% | 1397 |
|
|
2023
Q3 | $14.7M | Sell |
546,260
-21,228
| -4% | -$573K | 0.01% | 1238 |
|
|
2023
Q2 | $13.3M | Buy |
567,488
+328,581
| +138% | +$7.72M | ﹤0.01% | 1328 |
|
|
2023
Q1 | $3.28M | Sell |
238,907
-180,082
| -43% | -$2.47M | ﹤0.01% | 2120 |
|
|
2022
Q4 | $7.61M | Buy |
418,989
+152,173
| +57% | +$2.76M | ﹤0.01% | 1670 |
|
|
2022
Q3 | $3.98M | Buy |
266,816
+21,010
| +9% | +$313K | ﹤0.01% | 2032 |
|
|
2022
Q2 | $3.39M | Buy |
245,806
+96,199
| +64% | +$1.33M | ﹤0.01% | 2173 |
|
|
2022
Q1 | $1.74M | Buy |
149,607
+32,756
| +28% | +$382K | ﹤0.01% | 2569 |
|
|
2021
Q4 | $2.49M | Sell |
116,851
-8,012
| -6% | -$170K | ﹤0.01% | 2468 |
|
|
2021
Q3 | $3.35M | Buy |
124,863
+9,025
| +8% | +$242K | ﹤0.01% | 2427 |
|
|
2021
Q2 | $2.43M | Buy |
115,838
+37,130
| +47% | +$780K | ﹤0.01% | 2611 |
|
|
2021
Q1 | $1.85M | Sell |
78,708
-3,800
| -5% | -$89.3K | ﹤0.01% | 2657 |
|
|
2020
Q4 | $1.16M | Buy |
82,508
+16,130
| +24% | +$226K | ﹤0.01% | 2750 |
|
|
2020
Q3 | $834K | Buy |
66,378
+13,247
| +25% | +$166K | ﹤0.01% | 2762 |
|
|
2020
Q2 | $755K | Buy |
+53,131
| New | +$755K | ﹤0.01% | 2740 |
|